- strength
- 250 mg
- COMPOSITION
- Each contains Crizotinib 250 mg
- AVAILABLE AS
- Crizotinib Tablets
- PHARMACOLOGICAL ACTION :
- Crizotinib is a selective small-molecule inhibitor of the ALK receptor tyrosine kinase (RTK) and its
- USED FOR
- Crizotinib as monotherapy is indicated for: The first-line treatment of adults with anaplastic lymp
- SIDE EFFECTS
- Neutropenia, Anaemia, Leukopenia, Decreased appetite, Hypophosphataemia, Neuropathy, Dysgeusia, Vis